FDA NDC
DABIGATRAN ETEXILATE
This name is from the loaded FDA file.
Source: FDA NDC Directory, live from openFDA. Publisher page
- NDC
- 59651-974
- Proprietary name
- DABIGATRAN ETEXILATE
- Nonproprietary name
- DABIGATRAN ETEXILATE
- Labeler
- Aurobindo Pharma Limited
- Dosage form
- CAPSULE
- Strength
- 110 mg/1
Run it in Rivvi
Which 2027 plans near you dropped or restricted DABIGATRAN ETEXILATE?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan, from the CMS Part D files.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.